ABSTRACT
COVID-19 Pandemic has had a huge impact on mental health in population, becoming a public health problem. Our country has been affected in social, political and economical fields, causing a great impact on physical and mental health, and also with worldwide numerous human losses. Children and adolescents are a particularly vulnerable population, due to the risks that the pandemic has entailed, for their psychological development, social interaction, the influence of stress on neuroendocrine responses and also as neuropsychiatric manifestations with increased reports by researchers, without certainty of possible future damage. The objective of this paper is to review the possible causes and impact on psychosocial development and neuropsychiatric disorders in children and adolescents, and the individual and family factors that predispose to emotional, cognitive and behavioral reactions in pediatric population, searching to give a comprehensive view of the mental health problems in the pediatric population caused by the pandemic. © 2022 Instituto Nacional de Pediatria. All rights reserved.
ABSTRACT
Environmental factors and infectious diseases are closely related, mathematical models seek to explain these interactions, however, the same analytical practices are often observed with infectious diseases despite substantial differences from non-infectious diseases that can result in analytical challenges.
ABSTRACT
Individuals with malignancies and COVID-19 have a lower survival compared with the general population. However, the information about the impact of COVID-19 on the whole hematological population is scarce. We aimed to describe the 30th day overall survival (OS) after COVID-19 infection in patients with a hematological disease in Argentina. A completely anonymous survey from the Argentine Society of Hematology was delivered to all the hematologists in Argentina;it started in April 2020. A cut-off to analyze the data was performed in December 2020 and, finally, 419 patients were reported and suitable for the analysis (average age: 58 years, 90% with malignant diseases). After the COVID-19 diagnosis, the 30-day OS for the whole population was 80.2%. From the entire group (419), 101 (24.1%) individuals required intensive care unit admission, where the 30-day OS was 46.6%. Among allogeneic stem cell transplant recipients, the 30-day OS was 70.3%. Factors associated with a low OS were two or more comorbidities, an active hematological disease and history of chemotherapy. In individuals with the three factors, the 30-day OS was 49.6% while the 30-day OS in those without those factors was 100%. Patients with hematological diseases have a higher mortality than the general population. This group represents a challenge and requires careful decision-making of the treatment in order not to compromise the chances of cure.